Watson Recalls Loxapine Capsules Due to Outdated Patient Outsert
Watson Laboratories is recalling 18,902 bottles of Loxapine 50mg capsules because an outdated patient outsert was used during packaging.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which indicates the product is not likely to cause adverse health consequences. The issue is a documentation/packaging error involving an outdated outsert.
Plain-English summary
Watson Laboratories Inc. is recalling 18,902 bottles of Loxapine Capsules USP, 50mg, 100 count. The recall is due to the use of an outdated version of a patient outsert during the packaging process. The affected product is a prescription-only medication manufactured in Corona, California.
The recall covers nationwide distribution. The specific lot numbers involved are 104432A, 104433A, 121344A, 127024A, and 144290A. The product is identified by NDC # 0591-0372-01.
Consumers and healthcare providers should check their inventory for the listed lot numbers. If the product is found, it should be returned to the pharmacy or distributor for replacement or refund. No specific instructions for immediate disposal are provided in the source text.
The recalled product
- Product
- LOXAPINE (LOXAPINE)
- Brand
- LOXAPINE
- Manufacturer
- Watson Laboratories Inc
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 18,902
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot #s: 104432A
- 104433A
- 121344A
- 127024A
- 144290A
UPCs (3)
- 0305910369019
- 0305910370015
- 0305910372019
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 5 recalled by Watson Laboratories Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same brand · LOXAPINE
- LowWatson Loxapine Capsules Recalled for Outdated Patient Outsert Labeling
FDA (Drugs) · 2012-07-11
- LowWatson Recalls Loxapine Capsules Due to Outdated Patient Outsert Labeling
FDA (Drugs) · 2012-07-11
Same manufacturer · Watson Laboratories Inc
See all →- ModerateWatson Recalls Hydrocodone and Acetaminophen Tablets Due to Broken Tablets
FDA (Drugs) · 2014-02-05
- SevereWatson Recalls Carisoprodol Tablets Due to Metal Particulates
FDA (Drugs) · 2014-01-15
- ModerateWatson Recalls Next Choice Emergency Contraceptive Tablets Due to Breakage
FDA (Drugs) · 2013-10-16
- SevereWatson Recalls Oxycodone and Acetaminophen Tablets Due to Foreign Contamination
FDA (Drugs) · 2013-10-09
- LowWatson Recalls Hydrocodone and Acetaminophen Tablets Due to Defective Seals
FDA (Drugs) · 2013-09-25
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02